Welcome to Amgen Inc. Q3 2024 Earnings Conference Call!
Meet the Key Players
During the conference call, you will have the opportunity to hear from the following key figures at Amgen:
- Justin Claeys – VP, Investor Relations
- Robert Bradway – Chairman, CEO & President
- Murdo Gordon – EVP, Global Commercial Operations
- Vikram Karnani – EVP & President, Global Commercial Operations & Medical Affairs (Rare Disease)
- James Bradner – EVP, Research and Development & Chief Scientific Officer
- Peter Griffith – EVP & CFO
Conference Call Participants
Some of the participants in the conference call include:
- Salveen Richter from Goldman Sachs
- Olivia Brayer from Cantor Fitzgerald
- Michael Yee from Jefferies
- Courtney Breen from Bernstein
- Umer Raffat from Evercore ISI
Opening Remarks
Hello everyone, my name is Julianne, and I will be your conference facilitator for Amgen’s Third Quarter 2024 Financial Results Conference Call. All lines are muted to prevent background noise, so let’s dive into the exciting updates!
The Future of Amgen
Amgen is a company dedicated to improving the lives of patients through innovative biotechnology. With a strong leadership team and a commitment to research and development, Amgen is poised for continued growth and success in the coming years.
Financial Results
Stay tuned to hear about the financial results for the third quarter of 2024, including key performance indicators, market insights, and strategic initiatives driving Amgen’s success.
Q&A Session
After the presentations, there will be a Q&A session where participants can ask questions and engage with Amgen’s leadership team. This is a great opportunity to gain further insights into the company’s performance and future outlook.
How Will This Impact Me?
As an investor or stakeholder in Amgen, the Q3 2024 earnings conference call provides valuable insights into the company’s financial performance and strategic direction. By listening to the updates from key executives and analysts, you can make informed decisions about your investment in Amgen.
How Will This Impact the World?
Amgen’s success and innovation in biotechnology have the potential to impact the world by bringing cutting-edge treatments and therapies to patients around the globe. The advancements made by Amgen in rare diseases and other medical areas have the power to improve healthcare outcomes and quality of life for millions of people.
In Conclusion
Thank you for joining us for Amgen’s Q3 2024 Earnings Conference Call. We hope you found the updates and insights valuable and informative. Stay tuned for more exciting developments from Amgen as we continue our mission to serve patients and drive innovation in biotechnology.
